Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Jul 19;13(7):e1002087.
doi: 10.1371/journal.pmed.1002087. eCollection 2016 Jul.

Effects of Saturated Fat, Polyunsaturated Fat, Monounsaturated Fat, and Carbohydrate on Glucose-Insulin Homeostasis: A Systematic Review and Meta-analysis of Randomised Controlled Feeding Trials

Affiliations
Review

Effects of Saturated Fat, Polyunsaturated Fat, Monounsaturated Fat, and Carbohydrate on Glucose-Insulin Homeostasis: A Systematic Review and Meta-analysis of Randomised Controlled Feeding Trials

Fumiaki Imamura et al. PLoS Med. .

Abstract

Background: Effects of major dietary macronutrients on glucose-insulin homeostasis remain controversial and may vary by the clinical measures examined. We aimed to assess how saturated fat (SFA), monounsaturated fat (MUFA), polyunsaturated fat (PUFA), and carbohydrate affect key metrics of glucose-insulin homeostasis.

Methods and findings: We systematically searched multiple databases (PubMed, EMBASE, OVID, BIOSIS, Web-of-Knowledge, CAB, CINAHL, Cochrane Library, SIGLE, Faculty1000) for randomised controlled feeding trials published by 26 Nov 2015 that tested effects of macronutrient intake on blood glucose, insulin, HbA1c, insulin sensitivity, and insulin secretion in adults aged ≥18 years. We excluded trials with non-isocaloric comparisons and trials providing dietary advice or supplements rather than meals. Studies were reviewed and data extracted independently in duplicate. Among 6,124 abstracts, 102 trials, including 239 diet arms and 4,220 adults, met eligibility requirements. Using multiple-treatment meta-regression, we estimated dose-response effects of isocaloric replacements between SFA, MUFA, PUFA, and carbohydrate, adjusted for protein, trans fat, and dietary fibre. Replacing 5% energy from carbohydrate with SFA had no significant effect on fasting glucose (+0.02 mmol/L, 95% CI = -0.01, +0.04; n trials = 99), but lowered fasting insulin (-1.1 pmol/L; -1.7, -0.5; n = 90). Replacing carbohydrate with MUFA lowered HbA1c (-0.09%; -0.12, -0.05; n = 23), 2 h post-challenge insulin (-20.3 pmol/L; -32.2, -8.4; n = 11), and homeostasis model assessment for insulin resistance (HOMA-IR) (-2.4%; -4.6, -0.3; n = 30). Replacing carbohydrate with PUFA significantly lowered HbA1c (-0.11%; -0.17, -0.05) and fasting insulin (-1.6 pmol/L; -2.8, -0.4). Replacing SFA with PUFA significantly lowered glucose, HbA1c, C-peptide, and HOMA. Based on gold-standard acute insulin response in ten trials, PUFA significantly improved insulin secretion capacity (+0.5 pmol/L/min; 0.2, 0.8) whether replacing carbohydrate, SFA, or even MUFA. No significant effects of any macronutrient replacements were observed for 2 h post-challenge glucose or insulin sensitivity (minimal-model index). Limitations included a small number of trials for some outcomes and potential issues of blinding, compliance, generalisability, heterogeneity due to unmeasured factors, and publication bias.

Conclusions: This meta-analysis of randomised controlled feeding trials provides evidence that dietary macronutrients have diverse effects on glucose-insulin homeostasis. In comparison to carbohydrate, SFA, or MUFA, most consistent favourable effects were seen with PUFA, which was linked to improved glycaemia, insulin resistance, and insulin secretion capacity.

PubMed Disclaimer

Conflict of interest statement

I have read the journal's policy and the authors of this manuscript have the following competing interests: DM reports ad hoc honoraria or consulting from Boston Heart Diagnostics, Haas Avocado Board, Astra Zeneca, GOED, DSM, and Life Sciences Research Organization; chapter royalties from UpToDate; and scientific advisory board, Elysium Health. Harvard University has been assigned patent US8889739 B2, listing DM as one of three co-inventors, for use of trans-palmitoleic acid in identifying and treating metabolic disease. RM and JHYW received research support from Unilever R&D (project reference number MA-2015-01161) for work on fatty acid biomarkers and incident cardiometabolic diseases.

Figures

Fig 1
Fig 1. Flow diagram of systematic review of published trials evaluating effects of isocaloric replacement between macronutrient consumption on glucose homeostasis.
*See S3 Text for details of the databases, eligibility criteria, search terms, and prior review articles.
Fig 2
Fig 2. Effects on fasting glucose of isocaloric replacements between carbohydrate (CHO), saturated fat (SFA), monounsaturated fat (MUFA), and polyunsaturated fat (PUFA) in randomised controlled feeding trials.
Values represent pooled mean effects (95% CI) of specified macronutrient replacements, with other macronutrients held constant. *Significant heterogeneity across strata after correction for false-discovery rate (exploration of multiple characteristics for heterogeneity). †Estimates not shown due to wide 95% CIs; see S3 Table for numeric information. 1 mg/dL = 0.0555 mmol/L.
Fig 3
Fig 3. Effects on fasting insulin of isocaloric replacements between carbohydrate (CHO), saturated fat (SFA), monounsaturated fat (MUFA), and polyunsaturated fat (PUFA) in randomised controlled feeding trials.
Values represent pooled mean effects (95% CI) of specified macronutrient replacements, with other macronutrients held constant. No significant sources of heterogeneity were detected. †Estimates not shown due to wide, 95% CIs; see S3 Table for numeric information. 1 μIU/mL = 6 pmol/L.

Similar articles

Cited by

References

    1. NCD Risk Factor Collaboration. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants. Lancet. 2016;387(10027):1513–30. 10.1016/S0140-6736(16)00618-8 - DOI - PMC - PubMed
    1. International Diabetes Federatoin. The Global Burden In: IDF Diabetes Atlas. 6th ed. Brussels, Belgium: International Diabetes Federation; 2013. p. 29–49.
    1. Deakin T, Duncan A, Dyson P, Frost G, Harrison Z, Kelly T, et al. Evidence-based nutrition guidelines for the prevention and management of diabetes. Kelly T, Dyson P, editors. 2011. Available:https://www.diabetes.org.uk/About_us/What-we-say/Food-nutrition-lifestyl... (accessed 2016 Apr 29) - PubMed
    1. Evert AB, Boucher JL, Cypress M, Dunbar SA, Franz MJ, Mayer-Davis EJ, et al. Nutrition therapy recommendations for the management of adults with diabetes. Diabetes Care. 2013;36(11):3821–42. 10.2337/dc13-2042 - DOI - PMC - PubMed
    1. Fats and fatty acids in human nutrition Roma, Italy: Food and Agriculture Organization; 2010.

MeSH terms